|
|
|
|
|
The Breast Cancer Research Foundation was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit 501(c) (3) organization dedicated to funding innovative clinical and genetic research. A minimum of 85 cents of each dollar donated to the Foundation goes directly to breast cancer research and awareness programs. Since its inception, the Foundation has raised more than $125 million - over $25 million in fiscal year 2005 alone - to support clinical and genetic research at medical institutions across the globe conducting the most advanced and promising breast cancer research that will help lead to prevention and a cure in our lifetime. In October 2005, the Foundation awarded over $22 million in new grants to 110 researchers across the United States and in Canada, Europe, Israel, and Latin America. The Foundation invests in the most brilliant minds in breast cancer. For example, Harvard Medical School investigators announced in February 2006 that they have created the first publicly available library of reliably expressible proteins of a human disease, in this case for breast cancer. The scientists, whose work has been funded generously by BCRF since 2001, have identified 1,300 genes potentially involved in breast cancer development. Their achievement will allow researchers to track cancer-causing proteins, with the goal of learning how to impede them. This will radically improve breast cancer treatment and prevention and save the lives of thousands of women and men. It adds to recent important discoveries, also supported by BCRF, in the areas of targeted therapies for breast cancer and nutritional prevention of cancer recurrence. The Breast Cancer Research Foundation has received the highest rating from Charity Navigator, four stars,for five consecutive years, which means BCRF has outperformed over 98.7% of more than 5,000 evaluated charities in efficiently managing finances. Money Magazine named BCRF one of America’s eight top charities www.bcrfcure.org |
